Bezlotoxumab is associated with a reduction in cumulative inpatient-days: Analysis of the hospitalization data from the MODIFY I and II clinical trials

Anirban Basu, Vimalanand S. Prabhu, Mary Beth Dorr, Yoav Golan, Erik R. Dubberke, Oliver A. Cornely, Sebastian M. Heimann, Alison Pedley, Ruifeng Xu, Mary E. Hanson, Stephen Marcella

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Fingerprint

Dive into the research topics of 'Bezlotoxumab is associated with a reduction in cumulative inpatient-days: Analysis of the hospitalization data from the MODIFY I and II clinical trials'. Together they form a unique fingerprint.

Medicine & Life Sciences